NDC 76045-001 – Midazolam
Midazolam Hydrochloride 2 mg/2mL · Injection, Solution · Intramuscular, Intravenous
Product NDC76045-001
Product details
- Brand name
- Midazolam
- Generic name
- Midazolam Hydrochloride
- Labeler
- Fresenius Kabi USA, LLC
- Dosage form
- Injection, Solution
- Route
- Intramuscular, Intravenous
- Marketing category
- ANDA · ANDA203460
- Marketed since
- October 3, 2014
- Listing expires
- December 31, 2026
- Pharmacologic class
- Benzodiazepine
Active ingredients
- Midazolam Hydrochloride 2 mg/2mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 76045-001-20 | 24 BLISTER PACK in 1 CARTON (76045-001-20) / 1 SYRINGE, GLASS in 1 BLISTER PACK (76045-001-00) / 2 mL in 1 SYRINGE, GLASS | Oct 3, 2014 |
Recalls mentioning this NDC
- D-0152-2018 Jan 10, 2018 · Class I
Labeling: Label MIX-UP. Blister Packages, Labeled as Midazolam injection, USP, 2 mg / 2 ml, Containing Syringes of Ondansetron Injection, USP, 4 mg / 2 mL
Other Midazolam products
- 55154-4743 Midazolam Hydrochloride 1 mg/mL · Injection, Solution · Cardinal Health 107, LLC
- 63323-411 Midazolam Hydrochloride 1 mg/mL · Injection, Solution · Fresenius Kabi USA, LLC
- 63323-412 Midazolam Hydrochloride 5 mg/mL · Injection, Solution · Fresenius Kabi USA, LLC
- 76045-002 Midazolam Hydrochloride 5 mg/mL · Injection, Solution · Fresenius Kabi USA, LLC
- 76045-211 Midazolam Hydrochloride 2 mg/2mL · Injection, Solution · Fresenius Kabi USA, LLC
- 76045-003 Midazolam Hydrochloride 10 mg/2mL · Injection, Solution · Fresenius Kabi USA, LLC
- 0404-9915 Midazolam Hydrochloride 5 mg/mL · Injection, Solution · Henry Schein, Inc.
- 0409-0001 Midazolam Hydrochloride 1 mg/mL · Injection, Solution · Hospira, Inc.
- 0409-2305 Midazolam Hydrochloride 1 mg/mL · Injection, Solution · Hospira, Inc.
- 0409-2308 Midazolam Hydrochloride 5 mg/mL · Injection, Solution · Hospira, Inc.
- 0409-2587 Midazolam Hydrochloride 1 mg/mL · Injection, Solution · Hospira, Inc.
- 0409-2596 Midazolam Hydrochloride 5 mg/mL · Injection, Solution · Hospira, Inc.